Omacetaxine mepesuccinate is a protein translation inhibitor derived from the alkaloid cephalotaxine, used clinically to treat chronic myeloid leukemia and other hematologic malignancies. Laboratories… Read more
![Chemical structure of (11bS,12S,14aR)-2,3,5,6,11b,12-Hexahydro-1H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepine-12,13-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F11bS12S14aR-235611b12-Hexahydro-1H-13dioxolo4545benzo12-dcyclopentabpyrrolo12-aazepine-1213-diol.png&w=3840&q=75)
![Chemical structure of (R)-1-((11bS,12S,14aR)-13-Hydroxy-2,3,5,6,11b,12-hexahydro-1H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-12-yl) 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)succinate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-1-11bS12S14aR-13-Hydroxy-235611b12-hexahydro-1H-13dioxolo4545benzo12-dcyclopentabpyrrolo12-aazepin-12-yl-4-methyl-2-hydroxy-2-4-hydroxy-4-methylpent.png&w=3840&q=75)
![Chemical structure of (R)-1-((11bS,12S,14aR)-13-Hydroxy-2,3,5,6,11b,12-hexahydro-1H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-12-yl) 4-methyl 2-hydroxy-2-(4-methylpent-4-en-1-yl)succinate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-1-11bS12S14aR-13-Hydroxy-235611b12-hexahydro-1H-13dioxolo4545benzo12-dcyclopentabpyrrolo12-aazepin-12-yl-4-methyl-2-hydroxy-2-4-methylpent-4-en-1-yl.png&w=3840&q=75)
Omacetaxine mepesuccinate is a protein translation inhibitor derived from the alkaloid cephalotaxine, used clinically to treat chronic myeloid leukemia and other hematologic malignancies. Laboratories rely on high-quality reference standards for this compound, including related impurities, process degradation products, and metabolites, to ensure accuracy in regulatory compliance and pharmaceutical development. These compounds are essential for impurity profiling, allowing analysts to identify, quantify, and monitor potential contaminants within the drug substance. Additionally, stable isotope labelled versions serve as critical internal standards for mass spectrometry-based assays, providing precise quantification during method validation and quality control processes. By utilizing these analytical tools, researchers can maintain rigorous standards in the assessment of potency, stability, and purity throughout the lifecycle of the drug.